Evidence map›Paper›PMID 39105756›Full record

ArticleThe Journal of cell biology2024

Cyclin B3 is a dominant fast-acting cyclin that drives rapid early embryonic mitoses.

Pablo Lara-Gonzalez, Smriti Variyar, Shabnam Moghareh, Anh Cao Ngoc Nguyen, Amrutha Kizhedathu, Jacqueline Budrewicz, Aleesa Schlientz, Neha Varshney, Andrew Bellaart, Karen Oegema and 2 more

Abstract read
In one paragraph

Article in The Journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Pablo Lara-GonzalezDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID 0000-0002-8863-9006
Smriti Variyar *Department of Cell and Developmental Biology, University of California, San Diego, San Diego, CA, USA.ORCID 0009-0007-8769-0022
Shabnam Moghareh *Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID 0009-0007-8976-9156
Anh Cao Ngoc Nguyen *Department of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID 0009-0000-0597-8145
Amrutha KizhedathuDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID 0009-0005-9034-1427
Jacqueline BudrewiczLudwig Institute for Cancer Research , La Jolla, CA, USA.ORCID 0000-0003-2721-6373
Aleesa SchlientzDepartment of Cell and Developmental Biology, University of California, San Diego, San Diego, CA, USA.ORCID 0000-0002-7281-8851
Neha VarshneyDepartment of Cell and Developmental Biology, University of California, San Diego, San Diego, CA, USA.ORCID 0000-0002-2780-3028
Andrew BellaartDepartment of Cell and Developmental Biology, University of California, San Diego, San Diego, CA, USA.ORCID 0009-0008-4260-3404
Karen OegemaLudwig Institute for Cancer Research , La Jolla, CA, USA.ORCID 0000-0001-8515-7514
Lee BardwellDepartment of Developmental and Cell Biology, University of California, Irvine, Irvine, CA, USA.ORCID 0000-0002-2393-8363
Arshad DesaiLudwig Institute for Cancer Research , La Jolla, CA, USA.ORCID 0000-0002-5410-1830

Funding

Kinetochore Specification and FunctionR01GM074215 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DESAI, ARSHAD · 2005 to 2025
$8.2M
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Mechanisms of CytokinesisR01GM147265 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OEGEMA, KAREN F · 2022 to 2025
$1.8M
Developmental regulation of the cell cycle machineryR35GM150786 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI Pablo Andres Lara-Gonzalez · 2023 to 2026
$1.5M
Acquisition of an Orbitrap Elite with ETDS10OD021724 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2016 to 2016
$600k
Dissecting the role of Aurora A kinase in patterning the cell cortex during cytokinesis.F32GM145068 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHLIENTZ, ALEESA · 2022 to 2023
$137k
Ludwig Institute for Cancer ResearchNIGMS NIH HHS F32 GM145068NIGMS NIH HHS R01 GM074215NIGMS NIH HHS R01 GM147265NIGMS NIH HHS R35 GM150786NIH HHS P40 OD010440NIH HHS S10 OD021724ODCDC CDC HHS P40 OD010440
6 · The paper itself

Abstract

Mitosis in early embryos often proceeds at a rapid pace, but how this pace is achieved is not understood. Here, we show that cyclin B3 is the dominant driver of rapid embryonic mitoses in the C. elegans embryo. Cyclins B1 and B2 support slow mitosis (NEBD to anaphase ∼600 s), but the presence of cyclin B3 dominantly drives the approximately threefold faster mitosis observed in wildtype. Multiple mitotic events are slowed down in cyclin B1 and B2-driven mitosis, and cyclin B3-associated Cdk1 H1 kinase activity is ∼25-fold more active than cyclin B1-associated Cdk1. Addition of cyclin B1 to fast cyclin B3-only mitosis introduces an ∼60-s delay between completion of chromosome alignment and anaphase onset; this delay, which is important for segregation fidelity, is dependent on inhibitory phosphorylation of the anaphase activator Cdc20. Thus, cyclin B3 dominance, coupled to a cyclin B1-dependent delay that acts via Cdc20 phosphorylation, sets the rapid pace and ensures mitotic fidelity in the early C. elegans embryo.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsCyclin B1Embryo, NonmammalianMitosisAnimalsCdc20 ProteinsCDC2 Protein KinaseCyclin BCyclin B2PhosphorylationCaenorhabditis elegans ProteinsCdc20 ProteinsCDC2 Protein KinaseCYB-3 protein, C elegansCyclin BCyclin B1Cyclin B2

Identifiers

PMID39105756
PMCPMC11303871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.